Management Change25 Sept 2026, 06:10 pm
Bal Pharma Directors' Designations Changed, Committees Reconstituted
AI Summary
Bal Pharma Ltd announced changes in director designations and reconstitution of statutory committees, effective October 1, 2026. Mr. Ravindra Kumar Kothari's designation changed from Non-Executive Director to Whole-Time Director (Executive Director), and Mr. Virupakshaya Himesh's from Whole-Time Director to Non-Executive Director. These changes were approved by shareholders at the 39th AGM. Consequently, Mr. Himesh has been inducted into the Nomination and Remuneration Committee (NRC) and Stakeholders' Relationship Committee (SRC), while Mr. Kothari has ceased to be a member of these committees. The changes were previously recommended by the NRC and approved by the Board.
Key Highlights
- Director designations changed effective October 1, 2026.
- Mr. Kothari appointed Executive Director; Mr. Himesh becomes Non-Executive Director.
- Statutory committees (NRC, SRC) reconstituted post-director changes.
- Shareholders approved these changes at the 39th AGM.
- Mr. Himesh joins NRC and SRC; Mr. Kothari exits them.
Price Impact
More from BALPHARMA